Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Ocular Cicatricial Pemphigoid
NCT00584935Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2006
- Primary completion
- Jan 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in ocular cicatricial pemphigoid (OCP), sponsored by University of Alabama at Birmingham. Started Jan 2006; status: completed.
02
Drugs
rituximab
03
Conditions
ocular cicatricial pemphigoid (OCP)
Beyond the preview
Go deeper on NCT00584935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584935.